Andrew Looka
Overview
Explore the profile of Andrew Looka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Itzhaki Ben Zadok O, Simitsis P, Jacobson C, Nadeem O, Frigault M, Raje N, et al.
Circulation
. 2024 Nov;
150(22):1815-1817.
PMID: 39585929
No abstract available.
2.
Looka A, Qualls D, Matthews D, Redd R, Sakellis C, Duffy C, et al.
Blood Adv
. 2024 Nov;
9(3):455-462.
PMID: 39546746
Lisocabtagene maraleucel (liso-cel) and axicabtagene ciloleucel (axi-cel) are anti-CD19 chimeric antigen receptor (CAR) T-cell therapies approved for relapsed and refractory large B-cell lymphoma (LBCL); however, there is currently no published...
3.
Aleissa M, Little J, Davey S, Saucier A, Zhou G, Gonzalez-Bocco I, et al.
Transplant Cell Ther
. 2023 Mar;
29(6):398.e1-398.e5.
PMID: 36906276
Patients receiving chimeric antigen receptor T cell (CAR-T) therapy may have impaired humoral responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations owing to their underlying hematologic malignancy, prior...
4.
Zhang K, Abdallah K, Ajmera P, Finos K, Looka A, Mekhael J, et al.
J Chem Inf Model
. 2021 Apr;
61(4):1545-1549.
PMID: 33797909
Here, we introduce CS-Annotate, a tool that uses assigned NMR chemical shifts to annotate structural features in RNA. At its core, CS-Annotate is a deployment of a multitask deep learning...